down arrow

Zenlabs Ethica

  • Market Cap: Micro Cap
  • Industry: Finance/NBFC
  • ISIN: INE546F01013
  • NSEID:
  • BSEID: 530697
INR
32.35
1.46 (4.73%)
BSENSE

Apr 11, 12:41 PM

BSE+NSE Vol: 302

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

32.0032.50

52 Week

27.3352.40
Valuation
Technical
Day's Volume

CASH

302 (-89.87%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

52.96%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.13%

  • Poor long term growth as Net Sales has grown by an annual rate of -3.30%
2

Flat results in Dec 24

3

Stock is technically in a Bearish range

4

With ROE of 3.2, it has a Very Expensive valuation with a 2 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Finance/NBFC

stock-summary
Market cap

INR 21 Cr (Micro Cap)

stock-summary
P/E

20.00

stock-summary
Industry P/E

20

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.11

stock-summary
Return on Equity

3.22%

stock-summary
Price to Book

1.96

Revenue and Profits (1 Year):
Net Sales:
13 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-21.86%
0%
-21.86%
1 Year
-20.89%
0%
-20.89%
2 Years
-50.25%
0%
-50.25%
3 Years
-7.17%
0.61%
-6.56%
4 Years
50.47%
0.83%
51.3%
5 Years
-8.23%
0.82%
-7.41%

Latest dividend: 0.2 per share ex-dividend date: Jul-29-2022

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-3.30%
EBIT Growth (5y)
23.73%
Net Debt to Equity (avg)
0
Institutional Holding
0
ROE (avg)
6.13%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
20
Price to Book Value
1.96
EV to EBIT
21.60
EV to EBITDA
11.25
EV to Capital Employed
1.49
EV to Sales
0.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.94%
ROE (Latest)
3.22%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Preet Remedies Limited (26.58%)

Highest Public shareholder

Hitesh Popatlal Oswal (6.79%)

Individual Investors Holdings

40.97%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -4.72% vs 8.01% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 80.00% vs 25.00% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.72",
          "val2": "13.35",
          "chgp": "-4.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.68",
          "val2": "0.61",
          "chgp": "11.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.24",
          "val2": "0.23",
          "chgp": "4.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.09",
          "val2": "0.05",
          "chgp": "80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.35%",
          "val2": "4.57%",
          "chgp": "0.78%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -6.98% vs -20.78% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -40.00% vs -80.77% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.71",
          "val2": "27.64",
          "chgp": "-6.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.23",
          "val2": "0.97",
          "chgp": "26.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.46",
          "val2": "0.37",
          "chgp": "24.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.09",
          "val2": "0.15",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.78%",
          "val2": "3.51%",
          "chgp": "1.27%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -11.12% vs -17.31% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -30.77% vs -70.45% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "38.43",
          "val2": "43.24",
          "chgp": "-11.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.91",
          "val2": "1.66",
          "chgp": "15.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.59",
          "chgp": "18.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.18",
          "val2": "0.26",
          "chgp": "-30.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.97%",
          "val2": "3.84%",
          "chgp": "1.13%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -12.45% vs -3.18% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -14.29% vs -40.24% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "58.56",
          "val2": "66.89",
          "chgp": "-12.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.40",
          "val2": "2.91",
          "chgp": "-17.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.83",
          "val2": "0.53",
          "chgp": "56.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.58",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.42",
          "val2": "0.49",
          "chgp": "-14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.10%",
          "val2": "4.35%",
          "chgp": "-0.25%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
12.72
13.35
-4.72%
Operating Profit (PBDIT) excl Other Income
0.68
0.61
11.48%
Interest
0.24
0.23
4.35%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.09
0.05
80.00%
Operating Profit Margin (Excl OI)
5.35%
4.57%
0.78%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -4.72% vs 8.01% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 80.00% vs 25.00% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
25.71
27.64
-6.98%
Operating Profit (PBDIT) excl Other Income
1.23
0.97
26.80%
Interest
0.46
0.37
24.32%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.09
0.15
-40.00%
Operating Profit Margin (Excl OI)
4.78%
3.51%
1.27%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -6.98% vs -20.78% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -40.00% vs -80.77% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
38.43
43.24
-11.12%
Operating Profit (PBDIT) excl Other Income
1.91
1.66
15.06%
Interest
0.70
0.59
18.64%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.18
0.26
-30.77%
Operating Profit Margin (Excl OI)
4.97%
3.84%
1.13%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -11.12% vs -17.31% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -30.77% vs -70.45% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
58.56
66.89
-12.45%
Operating Profit (PBDIT) excl Other Income
2.40
2.91
-17.53%
Interest
0.83
0.53
56.60%
Exceptional Items
0.00
-0.58
100.00%
Standalone Net Profit
0.42
0.49
-14.29%
Operating Profit Margin (Excl OI)
4.10%
4.35%
-0.25%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -12.45% vs -3.18% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -14.29% vs -40.24% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Zenlabs Ethica Ltd stock-summary
stock-summary
Zenlabs Ethica Ltd
Micro Cap
Finance/NBFC
Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993. The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
Company Coordinates stock-summary
Company Details
Plot No 194-195 3rd Flr Pha-II, Industrial Area Ram Darbar Chandigarh Chandigarh ( U T ) : 160002
stock-summary
Tel: 91-172-4651105/3920738
stock-summary
http://www.zenlabsindia.com; www.zenlabsethica.com
stock-summary
queries@zenlabsethica.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."